Case Study: How a PhD Student Turned a Thesis Into a Patent Portfolio

This is the story of a materials science researcher who navigated university IP ownership, technology transfer negotiations, and investor due diligence to build a patent-backed startup around her doctoral research — and the critical decisions that made the difference between retaining control and losing her own invention.

This case study is a realistic composite based on publicly documented university technology transfer outcomes. Names and specific details have been changed.

The Situation

Dr. Amira completed her PhD at a UK research university, developing a novel conductive polymer coating for flexible electronics. The coating solved a known problem — maintaining conductivity after repeated bending cycles — and had clear commercial applications in wearable health monitors, flexible displays, and soft robotics.

The invention was made using university equipment, during her funded PhD programme. Under her university's IP policy — standard across most research institutions globally — the university owned the IP. Amira was the inventor, but not the owner.

The Technology Transfer Negotiation

Amira approached the university's Technology Transfer Office (TTO) with a proposal: she wanted to form a spin-out company and license the technology from the university. The TTO had three options: license to Amira's spin-out, license to an established company, or let the IP lapse if neither route was viable.

The TTO offered terms: an exclusive licence in exchange for 5% equity in the spin-out plus a 3% royalty on net sales. Amira's attorney (funded through a university entrepreneurship programme) negotiated this to 3% equity plus a 2% royalty — with a provision that the equity percentage would not be diluted below 1.5% in future funding rounds, after which the university would receive additional equity only through pro-rata investment.

What she got right: She negotiated before incorporating the company. Once the company existed, the TTO would have negotiated with the company (where the university had less leverage over Amira personally). By negotiating the licence as a condition of incorporation, Amira retained more control.

What she nearly got wrong: The TTO's initial draft licence included a grant-back clause requiring any improvements developed by the spin-out to be assigned back to the university. Her attorney caught this and negotiated it to a non-exclusive licence-back — the university could use improvements in its own research but could not licence them to competitors.

The Patent Filing Strategy

The university had filed a UK patent application during Amira's PhD — covering the coating composition and a basic manufacturing method. But the claims were narrowly drafted around the specific polymer formulation used in the thesis experiments.

Amira's first investment of spin-out capital was hiring a patent attorney to file a new application — a continuation-in-part style filing (via a new UK application claiming priority) with significantly broader claims covering a genus of conductive polymer coatings with the key structural feature that enabled bending durability. The specification included five alternative polymer systems, three application methods, and two substrate configurations — all developed during the final months of her PhD but not included in the university's original filing.

She then filed a PCT application within 12 months, entering national phase in the US, EU, China, Japan, and South Korea — the five markets where flexible electronics manufacturing and sales were concentrated.

Total patent cost through national phase entry: approximately £45,000 — funded by a £75,000 Innovate UK Smart Grant.

The Investor Due Diligence

At month 18, Amira raised a £500K seed round from a deep-tech VC fund. The investor's IP counsel conducted due diligence examining:

• The university licence agreement (exclusive, perpetual, clearly documented)
• Chain of title from Amira as inventor to the university as owner to the spin-out as licensee
• All IP assignment agreements for the spin-out's two employees
• The patent portfolio (UK granted, PCT in national phase, no adverse office actions)
• Freedom-to-operate analysis (commissioned proactively by Amira before the investor asked)

The clean IP position was noted positively in the investment memo. The lead partner told Amira that two of the fund's previous investments had stalled during IP due diligence because of messy university licence terms — her proactive approach avoided this.

The Outcome

By Year 3, Amira's spin-out had: a granted UK patent, a granted US patent (Track One accelerated), a Chinese utility model registration, and EPO and JPO applications in prosecution. The first licensing deal — with a Japanese flexible display manufacturer — closed at a 4% royalty on products incorporating the coating.

Amira retained her position as CEO and chief scientist, with a 52% equity stake (post-dilution from the seed round and university equity).

The Lessons

Understand your university's IP policy before you invent. If you are a student or researcher, your employment or enrolment agreement almost certainly assigns IP to the institution. Know this before you create something valuable — and plan your negotiation strategy accordingly.

Negotiate the licence before incorporating. Once the company exists, the TTO negotiates with the company. Before incorporation, you are the inventor negotiating personally — a stronger position.

File broader claims than the thesis. A thesis describes one specific embodiment. A commercially valuable patent covers the underlying concept broadly. Invest in a second, broader filing that captures the full scope of the innovation.

Commission FTO proactively. Investors expect to see an FTO analysis. Producing one before they ask signals professionalism and de-risks the investment — often improving the valuation.

Keep the chain of title clean from day one. Every employee, contractor, and collaborator must have an IP assignment agreement in place before they begin work. A gap in the chain of title that surfaces during investor due diligence can delay or kill a funding round.

Sources

1. WIPO PCT System — International patent filing system used for multi-jurisdiction protection
2. USPTO Track One Prioritized Examination — Accelerated US examination programme referenced in the case study
3. Innovate UK (UKRI) — UK government innovation funding body that provided the Smart Grant
4. EPO Patent Filing — European Patent Office application procedures